These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19654419)

  • 41. Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial.
    Holme I; Boman K; Brudi P; Egstrup K; Gohlke-Baerwolf C; Kesäniemi YA; Malbecq W; Rossebø AB; Wachtell K; Willenheimer R; Pedersen TR
    Am J Cardiol; 2010 Jun; 105(12):1802-8. PubMed ID: 20538134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Commentary to the article: Kastelein JJ, Akdim F, Stroes ES, et al.; ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008; 358: 1431-43 ].
    Michałek A
    Kardiol Pol; 2008 May; 66(5):597-8, discussion 598-9. PubMed ID: 18630396
    [No Abstract]   [Full Text] [Related]  

  • 43. [On the current debate on lowering LDL cholesterol with ezetimibe].
    Schunn H
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2202; author reply 2202. PubMed ID: 20979010
    [No Abstract]   [Full Text] [Related]  

  • 44. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
    Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E; Davidson MH
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simvastatin and ezetimibe in addition to nonpharmacological risk factor modification for achieving new low-density lipoprotein cholesterol targets.
    Liska B; Khattab AA; Herrmann L; Abdel-Wahab M; Westphal R; Tölg R; Geist V; Richardt G
    Herz; 2008 Jul; 33(5):362-7. PubMed ID: 18773156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of ezetimibe in the management of patients with atherosclerosis.
    Hamilton P
    Coron Artery Dis; 2009 Mar; 20(2):169-74. PubMed ID: 19106797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ezetimibe 5 and 10 mg for lowering LDL-C: potential billion-dollar savings with improved tolerability.
    Baruch L; Gupta B; Lieberman-Blum SS; Agarwal S; Eng C
    Am J Manag Care; 2008 Oct; 14(10):637-41. PubMed ID: 18837641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [LDL cholesterol lowering therapy: no target value but personalised treatment].
    Simoons ML; Deckers JW
    Ned Tijdschr Geneeskd; 2015; 159():A8770. PubMed ID: 25923500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of ezetimibe in the United States and Canada.
    Jackevicius CA; Tu JV; Ross JS; Ko DT; Krumholz HM
    N Engl J Med; 2008 Apr; 358(17):1819-28. PubMed ID: 18375999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced hype.
    Harrison DG; Brown WV; Raggi P
    Am J Cardiol; 2008 Aug; 102(3):368-9. PubMed ID: 18638604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ezetimibe (Ezetrol) in patients with diabetes].
    Scheen AJ; Radermecker RP
    Rev Med Liege; 2009 Dec; 64(12):606-11. PubMed ID: 20143743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind clinical trial: comment on Ruggenenti et al.
    Sarigianni M; Katsiki N; Mikhailidis DP
    Diabetes Care; 2010 Oct; 33(10):e132; author reply e133. PubMed ID: 20876706
    [No Abstract]   [Full Text] [Related]  

  • 55. [Inegy: a powerful new medication for lowering LDL cholesterol].
    Rev Med Suisse; 2006 Jun; 2(70):1605. PubMed ID: 16838729
    [No Abstract]   [Full Text] [Related]  

  • 56. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia.
    Samaha FF; McKenney J; Bloedon LT; Sasiela WJ; Rader DJ
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5(8):497-505. PubMed ID: 18506154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ezetimibe in heart transplantation: initial experience.
    Moro J; Almenar L; Martínez-Dolz L; Izquierdo M; Agüero J; Sánchez-Lazaro I; Ortiz V; Salvador A
    Transplant Proc; 2007 Sep; 39(7):2389-92. PubMed ID: 17889199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H; Mendelsohn AA; Goodman SG; Jaffer S; Chen RY; Tjia S; Theriault L; Langer A; Leiter LA;
    Am J Cardiol; 2009 Sep; 104(6):798-804. PubMed ID: 19733714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ezetimibe added to statin therapy (EASY study) - an evaluation by Australian general practitioners.
    Simons LA; Symons J
    Aust Fam Physician; 2007; 36(1-2):90-2, 96. PubMed ID: 17252094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.